Document Detail

Weaknesses in Regional Primary Coronary Angioplasty Programs: Is There Still a Role for a Pharmaco-invasive Approach?
MedLine Citation:
PMID:  25037545     Owner:  NLM     Status:  In-Data-Review    
All guidelines recommend primary percutaneous coronary intervention as the default strategy for achieving reperfusion in ST-segment elevation myocardial infarction patients. These recommendations are based upon randomized trials which compared primary percutaneous coronary intervention with stand-alone intravenous fibrinolysis. Since the time these trials were performed, however, it has been shown in further trials that use of rescue percutaneous coronary intervention in patients without signs of reperfusion after lysis, and routine coronary angiography within 24h of the administration of lysis for all other patients, substantially improved the results of intravenous fibrinolytic treatment. This has led to proposing the pharmaco-invasive strategy as an alternative to primary percutaneous coronary intervention. Actually, it is not uncommon that circumstances prevent performing primary percutaneous coronary intervention within the recommended time limits set by the guidelines. In such cases, using a pharmaco-invasive strategy may constitute a valid alternative. Both the STREAM randomized trial and real-world experience, in particular the long-term results from the FAST-MI registry, suggest that the pharmaco-invasive strategy, when used in an appropriate population, compares favorably with primary percutaneous coronary intervention. Therefore, implementing a pharmaco-invasive strategy protocol may be an important complement to compensate for potential weaknesses in ST-segment elevation myocardial infarction networks.
Nicolas Danchin; Nelson Dos Santos Teixeira; Etienne Puymirat
Related Documents :
20653715 - Diuretic management in heart failure.
6870005 - Furazolidone-induced congestive cardiomyopathy in ducklings: myocardial ultrastructural...
19560695 - Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure...
875315 - Effects of antikaliuretic agents on cardiac electrophysiology--measurements in papillar...
1284155 - Intracoronary gallopamil during percutaneous transluminal coronary angioplasty.
19765215 - Neurohormonal activation in canine degenerative mitral valve disease: implications on p...
Publication Detail:
Type:  Journal Article     Date:  2014-06-27
Journal Detail:
Title:  Revista española de cardiología (English ed.)     Volume:  67     ISSN:  1885-5857     ISO Abbreviation:  Rev Esp Cardiol (Engl Ed)     Publication Date:  2014 Aug 
Date Detail:
Created Date:  2014-07-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101587954     Medline TA:  Rev Esp Cardiol (Engl Ed)     Country:  Spain    
Other Details:
Languages:  eng     Pagination:  659-65     Citation Subset:  IM    
Copyright Information:
Copyright © 2014 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Normal Left Ventricular Mechanics by Two-dimensional Speckle-tracking Echocardiography. Reference Va...
Next Document:  Medial Prefrontal-Hippocampal Connectivity and Motor Memory Consolidation in Depression and Schizoph...